Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.

Hoy SM, Keating GM.

Drugs. 2012 Mar 26;72(5):643-69. doi: 10.2165/11207560-000000000-00000. Review. Erratum in: Drugs. 2012 Apr 16;72(6):870-1.

PMID:
22439669
[PubMed - indexed for MEDLINE]
2.

Rasagiline: a review of its use in the management of Parkinson's disease.

Oldfield V, Keating GM, Perry CM.

Drugs. 2007;67(12):1725-47. Review.

PMID:
17683172
[PubMed - indexed for MEDLINE]
3.

Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.

Chen JJ, Swope DM, Dashtipour K.

Clin Ther. 2007 Sep;29(9):1825-49. Review.

PMID:
18035186
[PubMed - indexed for MEDLINE]
4.

Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.

Guay DR.

Am J Geriatr Pharmacother. 2006 Dec;4(4):330-46. Review.

PMID:
17296539
[PubMed - indexed for MEDLINE]
5.

Rasagiline.

Siddiqui MA, Plosker GL.

Drugs Aging. 2005;22(1):83-91; discussion 93-4. Review.

PMID:
15663351
[PubMed - indexed for MEDLINE]
6.

Ropinirole: a review of its use in the management of Parkinson's disease.

Matheson AJ, Spencer CM.

Drugs. 2000 Jul;60(1):115-37. Review.

PMID:
10929932
[PubMed - indexed for MEDLINE]
7.

The role of rasagiline in the treatment of Parkinson's disease.

Leegwater-Kim J, Bortan E.

Clin Interv Aging. 2010 May 25;5:149-56. Review.

PMID:
20517484
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Does levodopa slow or hasten the rate of progression of Parkinson's disease?

Fahn S; Parkinson Study Group.

J Neurol. 2005 Oct;252 Suppl 4:IV37-IV42. Review.

PMID:
16222436
[PubMed - indexed for MEDLINE]
9.

Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.

Dooley M, Markham A.

Drugs Aging. 1998 Jun;12(6):495-514. Review.

PMID:
9638397
[PubMed - indexed for MEDLINE]
10.

The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy.

Elmer LW, Bertoni JM.

Expert Opin Pharmacother. 2008 Nov;9(16):2759-72. doi: 10.1517/14656566.9.16.2759 . Review.

PMID:
18937611
[PubMed - indexed for MEDLINE]
11.

Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.

Henchcliffe C, Schumacher HC, Burgut FT.

Expert Rev Neurother. 2005 Nov;5(6):811-21. Review.

PMID:
16274338
[PubMed - indexed for MEDLINE]
12.

Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's disease.

Stocchi F.

Int J Clin Pract. 2006 Feb;60(2):215-21. Review.

PMID:
16451296
[PubMed - indexed for MEDLINE]
13.

[Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages].

Pagonabarraga J, Rodríguez-Oroz MC.

Rev Neurol. 2013 Jan 1;56(1):25-34. Review. Spanish.

PMID:
23250679
[PubMed - indexed for MEDLINE]
Free Article
14.

Rotigotine transdermal patch: a review of its use in the treatment of Parkinson's disease.

Sanford M, Scott LJ.

CNS Drugs. 2011 Aug;25(8):699-719. doi: 10.2165/11206750-000000000-00000. Review.

PMID:
21790211
[PubMed - indexed for MEDLINE]
15.

Medical management of levodopa-associated motor complications in patients with Parkinson's disease.

Jankovic J, Stacy M.

CNS Drugs. 2007;21(8):677-92. Review.

PMID:
17630819
[PubMed - indexed for MEDLINE]
16.

Monoamine oxidase B inhibitors for the treatment of Parkinson's disease: a review of symptomatic and potential disease-modifying effects.

Schapira AH.

CNS Drugs. 2011 Dec 1;25(12):1061-71. doi: 10.2165/11596310-000000000-00000. Review.

PMID:
22133327
[PubMed - indexed for MEDLINE]
17.

Monamine oxidase inhibitors: current and emerging agents for Parkinson disease.

Fernandez HH, Chen JJ.

Clin Neuropharmacol. 2007 May-Jun;30(3):150-68. Review.

PMID:
17545750
[PubMed - indexed for MEDLINE]
18.

Rasagiline in the pharmacotherapy of Parkinson's disease--a review.

Rascol O.

Expert Opin Pharmacother. 2005 Oct;6(12):2061-75. Review.

PMID:
16197359
[PubMed - indexed for MEDLINE]
19.

Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.

Chen JJ, Fernandez HH.

Drugs Aging. 2007;24(8):663-80. Review.

PMID:
17702535
[PubMed - indexed for MEDLINE]
20.

Rasagiline: A second-generation monoamine oxidase type-B inhibitor for the treatment of Parkinson's disease.

Chen JJ, Ly AV.

Am J Health Syst Pharm. 2006 May 15;63(10):915-28. Review.

PMID:
16675649
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk